However, in the early stages of cancer, NF-κB can potentially contribute to tumour suppression since DNA damage, oncogene activation and cellular stress induce DNA-binding and transcriptional activity of NF-κB, which is required for p53-dependent apoptosis. Here, TP53 is linked to cancer.